Clinical Use of Ibuprofen Is Associated with Slower FEV1 Decline in Children with Cystic Fibrosis
- 1 December 2007
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 176 (11), 1084-1089
- https://doi.org/10.1164/rccm.200702-181oc
Abstract
Rationale: High-dose ibuprofen in a 4-year controlled trial slowed FEV1 decline in young subjects with cystic fibrosis, but the effectiveness of ibuprofen has not been assessed in a large group of patients treated clinically with this therapy. Objectives: To assess the effect of ibuprofen therapy on FEV1 decline in children and adolescents with cystic fibrosis, using observational data from the Cystic Fibrosis Foundation Patient Registry. Methods: The rate of decline in FEV1 percent predicted over 2–7 years among patients age 6–17 years with FEV1 > 60% predicted, and who were treated with ibuprofen (1,365), was compared with patients of similar age and disease severity who were not treated with this therapy (8,960). Multilevel repeated-measures mixed-regression models were used to estimate rates of decline, adjusting for characteristics and therapies that influenced FEV1 decline. Adverse effects were compared among those treated versus not treated with ibuprofen. Measurements and Main Results: FEV1 declined less rapidly among patients treated with ibuprofen (difference, 0.60% predicted per year; 95% confidence interval, 0.31 to 0.89; P < 0.0001); a 29% reduction in slope based on an average decline of 2.08% predicted per year for patients not treated. Those treated with ibuprofen were more likely to have an episode of gastrointestinal bleeding requiring hospitalization, but the occurrence was rare in both groups (annual incidence, 0.37 vs. 0.14%; relative risk, 2.72; P < 0.001). Conclusions: Slower rates of FEV1 decline are seen in children and adolescents with cystic fibrosis who are treated with ibuprofen. The apparent benefits of ibuprofen therapy outweigh the small risk of gastrointestinal bleeding.This publication has 16 references indexed in Scilit:
- Use of high-dose ibuprofen in a pediatric cystic fibrosis centerJournal of Cystic Fibrosis, 2007
- Effect of Ibuprofen on Neutrophil Migration in Vivo in Cystic Fibrosis and Healthy SubjectsThe Journal of pharmacology and experimental therapeutics, 2003
- Estimating effectiveness in an observational study: A case study of dornase alfa in cystic fibrosisThe Journal of Pediatrics, 1999
- The Use of Anti-inflammatory Medications in Cystic FibrosisSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1999
- Transient Renal Failure Due to Simultaneous Ibuprofen and Aminoglycoside Therapy in Children with Cystic FibrosisThe New England Journal of Medicine, 1998
- Identifying Treatments That Halt Progression of Pulmonary Disease in Cystic FibrosisPediatric Research, 1997
- Cystic fibrosis.American Journal of Respiratory and Critical Care Medicine, 1996
- Effect of High-Dose Ibuprofen in Patients with Cystic FibrosisThe New England Journal of Medicine, 1995
- Informative Drop-Out in Longitudinal Data AnalysisJournal of the Royal Statistical Society Series C: Applied Statistics, 1994
- Ibuprofen in children with cystic fibrosis: Pharmacokinetics and adverse effectsThe Journal of Pediatrics, 1991